13F-HR filed by JOHNSON & JOHNSON
JOHNSON & JOHNSON filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-09, with 22 holding rows worth $343,711,000.
- Accession
- 0001567619-23-002139
- Filer
- CIK 200406
- Filed
- 2023-02-09
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 22 entries on the cover page, a total value of $343,711,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $343,711,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-20072. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJohnson & Johnson Innovation - JJDC, Inc.028-20073
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,629,173 | $81,328,000 | thousands, detected and multiplied | |
| CVRX INC | 126638105 | COMMON STOCK | 3,495,575 | $64,144,000 | thousands, detected and multiplied | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 6,641,064 | $43,300,000 | thousands, detected and multiplied | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 3,379,064 | $34,095,000 | thousands, detected and multiplied | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 2,449,183 | $26,721,000 | thousands, detected and multiplied | |
| XENCOR INC | 98401F105 | COMMON STOCK | 748,062 | $19,480,000 | thousands, detected and multiplied | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 357,939 | $14,869,000 | thousands, detected and multiplied | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 3,670,516 | $11,562,000 | thousands, detected and multiplied | |
| CUE HEALTH INC | 229790100 | COM | 5,548,864 | $11,486,000 | thousands, detected and multiplied | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 247,598 | $10,043,000 | thousands, detected and multiplied | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 1,000,000 | $7,290,000 | thousands, detected and multiplied | |
| VOR BIOPHARMA INC | 929033108 | COM | 1,074,658 | $7,146,000 | thousands, detected and multiplied | |
| ADICET BIO INC | 007002108 | COM | 728,944 | $6,517,000 | thousands, detected and multiplied | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 394,834 | $2,748,000 | thousands, detected and multiplied | |
| NANO X IMAGING LTD | M70700105 | ORD SHS | 196,228 | $1,448,000 | thousands, detected and multiplied | |
| SOMALOGIC INC | 83444K105 | COM | 281,052 | $705,000 | thousands, detected and multiplied | |
| BIOMX INC | 09090D103 | COM | 2,133,402 | $398,000 | thousands, detected and multiplied | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 169,629 | $190,000 | thousands, detected and multiplied | |
| TRACON PHARMACEUTICALS INC | 89237H209 | COM NEW | 84,003 | $125,000 | thousands, detected and multiplied | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 54,621 | $56,000 | thousands, detected and multiplied | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 66,951 | $35,000 | thousands, detected and multiplied | |
| GRAYBUG VISION INC COM | 38942Q103 | SHS | 49,547 | $25,000 | thousands, detected and multiplied |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-23-002139 | this filing | 2023-02-09 | acceptance time not in the bulk data set |